Select the poster to view it full size.
Personalized risk assessment in idiopathic scoliosis
- Question
- How much growth does this child have left? Bracing decisions depend on it, but today’s maturity scores are population-based and retrospective.
- Approach
- A survival model that reads each patient’s irregular clinic history, static features, and the collagen X (CXM) blood biomarker, and predicts time to growth cessation from any landmark age.
- Recognition
- John H. Moe Award at SRS (Sep 2025), first place at the NSF AIVO Summit (Oct 2025), second place at the Shriners State of Science Meeting (Jan 2026).








